Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,744,954,225
-$357,930,933 QoQ
Shares Held
2,984,392
+3.4% QoQ
Ownership
0.317%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 76%
None 24%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$3,474,000
PutShares
4,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $15,736,449,872 across 16 Drug Manufacturers - General names. LLY ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,779,406 | $3,368,238,000 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,984,392 | $2,744,954,225 | |
| 3 | ABBV |
AbbVie Inc.
|
11,068,310 | $2,407,246,738 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,262,708 | $1,956,241,142 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,470,718 | $1,605,449,043 | |
| 6 | AZN |
Astrazeneca PLC
|
5,747,087 | $1,133,440,495 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,287,230 | $1,015,621,242 | |
| 8 | AMGN |
Amgen Inc
|
2,023,367 | $711,921,677 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,744,954,225 | 2,984,392 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,102,885,158 | 2,887,264 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,266,232,080 | 2,970,160 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,274,723,103 | 2,918,070 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,444,408,657 | 2,959,655 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,306,868,012 | 2,988,171 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $3,474,000 | 4,500 | Put | Defined | 2025-02-14 | |
| 2024-09-30 | $2,590,613,473 | 2,924,141 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $2,480,632 | 2,800 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $2,741,401,003 | 3,027,901 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,338,165,777 | 3,005,509 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,837,046,725 | 3,151,456 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,972,995,581 | 3,673,218 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,925,560,590 | 4,105,848 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,745,305,767 | 5,082,132 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,964,824,565 | 5,370,721 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,038,307,535 | 6,303,719 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,361,437,444 | 7,283,217 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,420,457,369 | 8,452,203 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,203,145,355 | 7,976,053 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,914,588,196 | 8,286,467 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,004,533,574 | 8,733,590 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,559,882,918 | 8,349,657 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,256,323,073 | 7,440,909 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $909,420,372 | 6,143,902 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,004,617,581 | 6,119,001 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $789,403,636 | 5,690,626 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||